Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$515.08 - $576.87 $55 Million - $61.6 Million
-106,725 Reduced 53.11%
94,221 $50.9 Million
Q4 2023

Feb 13, 2024

SELL
$391.37 - $557.56 $4.68 Million - $6.67 Million
-11,963 Reduced 5.62%
200,946 $112 Million
Q3 2023

Nov 13, 2023

SELL
$432.42 - $556.67 $196,751 - $253,284
-455 Reduced 0.21%
212,909 $93.1 Million
Q2 2023

Aug 11, 2023

SELL
$450.7 - $503.61 $112,675 - $125,902
-250 Reduced 0.12%
213,364 $107 Million
Q1 2023

May 12, 2023

SELL
$406.01 - $514.59 $1.74 Million - $2.21 Million
-4,295 Reduced 1.97%
213,614 $107 Million
Q4 2022

Feb 13, 2023

SELL
$324.64 - $441.27 $1.67 Million - $2.26 Million
-5,130 Reduced 2.3%
217,909 $88.9 Million
Q3 2022

Nov 14, 2022

BUY
$325.8 - $407.78 $23.7 Million - $29.7 Million
72,740 Added 48.4%
223,039 $72.7 Million
Q2 2022

Aug 12, 2022

BUY
$327.37 - $553.44 $49.2 Million - $83.2 Million
150,299 New
150,299 $52.7 Million

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $37.6B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Champlain Investment Partners, LLC Portfolio

Follow Champlain Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Champlain Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Champlain Investment Partners, LLC with notifications on news.